THERATARGET, INC. — Department of Health and Human Services STTR Phase I: 106
THERATARGET, INC. — STTR Phase I award from Department of Health and Human Services.
- Amount
- $400,000
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- STTR · Phase I
- Topic
- 106
- Solicitation
- PA16-303
- NAICS
- —
- Place of performance
- UT
- Period
- 2017-08-15 → 2020-01-31
Description
NARRATIVE This STTR Phase I proposal details the rationale and the research plan for the development of a novel liquid embolizing agent composed of the genetically engineered protein polymerSELPsilk elastinlike proteinKto embolize cerebral aneurysmsThe SELP embolic would reduce the risk of aneurysm rupture while minimizing the risk of recanalization after treatment and providing a platform for delivering newly developed drugs or cell therapies directly to the aneurysmal sacThis work will result in an embolic that can potentially improve aneurysm healingdeliver therapeutics locallyand reduce the risks associated with the embolization of cerebral arteries